MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas
Authors:
Open Access
- 7 November 2016
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 36 (16) , 2275-2285
Abstract
Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma. We generated a mouse model of mammary epithelial-specific Ccn6 deletion by developing a floxed Ccn6 mouse which was bred with an MMTV-Cre mouse. Ccn6fl/fl;MMTV-Cre mice displayed severe defects in ductal branching and abnormal age-related involution compared to littermate controls. Ccn6fl/fl;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas. Global gene expression profiling of Ccn6fl/fl mammary carcinomas and comparison of orthologous genes with a human metaplastic carcinoma signature revealed a significant overlap of 87 genes (P=5 × 10−11). Among the shared deregulated genes between mouse and human are important regulators of epithelial morphogenesis including Cdh1, Ck19, Cldn3 and 4, Ddr1, and Wnt10a. These results document a causal role for Ccn6 deletion in the pathogenesis of metaplastic carcinomas with histological and molecular similarities with human disease. We provide a platform to study new targets in the diagnosis and treatment of human metaplastic carcinomas, and a new disease relevant model in which to test new treatment strategies.Keywords
This publication has 52 references indexed in Scilit:
- Conditional Wwox Deletion in Mouse Mammary Gland by Means of Two Cre Recombinase ApproachesPLOS ONE, 2012
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsNature Reviews Drug Discovery, 2011
- Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transitionLaboratory Investigation, 2011
- CCN1/CYR61: the very model of a modern matricellular proteinCellular and Molecular Life Sciences, 2011
- CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancerJournal of Cell Science, 2011
- Blockade of CCN6 (WISP3) Activates Growth Factor–Independent Survival and Resistance to Anoikis in Human Mammary Epithelial CellsCancer Research, 2010
- Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical StudiesJournal of Mammary Gland Biology and Neoplasia, 2009
- Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the BreastClinical Cancer Research, 2008
- Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literatureBreast Cancer Research and Treatment, 2006
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004